FindTrial
Sign In

To investigate the standard programme of endoscopic submucosal tunnelling (ESDTT) and conventional endoscopic submucosal dissection (ESD) for the treatment of early esophagus, stomach, colorectal cancer and precancerous lesions

To investigate the standard programme of endoscopic submucosal tunnelling (ESDTT) and conventional endoscopic submucosal dissection (ESD) for the treatment of early esophagus, stomach, colorectal cancer and precancerous lesions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17012379
Enrollment
Unknown
Registered
2017-08-15
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophagus, stomach, colorectal cancer and precancerous lesions

Interventions

Group 1:endoscopic submucosal tunnel dissection
Group 2:Routine endoscopic submucosal dissection

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: tumor invasion depth no more than sm1; no evidence of lymph node or distant metastasis;

Exclusion criteria

Exclusion criteria: tumor invasion depth more than sm1; lymph node or distant metastasis;

Design outcomes

Primary

MeasureTime frame
En bloc dissection;R0 resection rate;curative resection rate;Dissection speed;—

Secondary

MeasureTime frame
Stenosis;—

Countries

China

Contacts

Public ContactYang Jinlin

West China Hospital, Sichuan University

mouse-577@163.com+86 18980602058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026